301221-19-2

Basic information

• Product Name: TERT-BUTYL 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)PIPERIDINE-1-CARBOXYLATE
• Synonyms: TERT-BUTYL 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)PIPERIDINE-1-CARBOXYLATE;1-Piperidinecarboxylicacid,4-iMidazo[1,2-a]pyridin-3-yl-,1,1-diMethylethylester;tert-butyl 4-(H-imidazo[1,2-a]pyridin-3-yl)piperidine-1-carboxylate
• CAS NO: 301221-19-2
• Molecular Formula: C17H23N3O2
• Molecular Weight: 301.38
• Mol File: 301221-19-2.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: TERT-BUTYL 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)PIPERIDINE-1-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)PIPERIDINE-1-CARBOXYLATE(301221-19-2)
• EPA Substance Registry System: TERT-BUTYL 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)PIPERIDINE-1-CARBOXYLATE(301221-19-2)

Safety Data

• Hazardous Substances Data: 301221-19-2(Hazardous Substances Data)

Upstream product

• 301221-63-6 tert-butyl 4-(1-bromo-2-oxoethyl)piperidine-1-carboxylate 
• 504-29-0 2-aminopyridine 
• 89151-44-0 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester 
• 142374-19-4 tert-butyl 4-(formylmethyl)piperidine-1-carboxylate 
• 135716-08-4 tert-butyl 4-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate 
• 135716-09-5 tert-butyl 4-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate 
• 881017-93-2 tert‐butyl 4‐(1‐bromo‐2‐ethoxy‐2‐oxoethyl)piperidine‐1‐carboxylate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 

Relevant articles and documents

METALLO-BETA-LACTAMASE INHIBITORS

The present invention relates to compounds of formula (I) that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.

Discovery of imidazo[1,5-c]imidazol-3-ones: Weakly basic, orally active factor Xa inhibitors

The coagulation enzyme factor Xa (FXa) has been recognized as a promising target for the development of new antithrombotic agents. We previously found compound 1 to be an orally bioavailable FXa inhibitor in fasted monkeys; however, 1 showed poor bioavail

Pyrrolidine modulators of chemokine receptor activity

The present invention is directed to pyrrolidine compounds of the formula I: (wherein R1, R2, R3, R4, R5, R6, R14and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3.